Two procedures in one intelligently designed device

The OMNI™ Surgical System is a manually operated device indicated for the delivery of small amounts of viscoelastic fluid during ophthalmic surgery through a custom microcatheter. It is also indicated for the cutting of trabecular meshwork when a trabeculotomy is indicated.

Transluminal Viscoelastic Delivery

With its unique implant-free approach, the OMNI™ Surgical System lets you access Schlemm’s canal with the microcatheter through a single clear corneal incision. Intelligently engineered with an internal reservoir delivering a controlled amount of viscoelastic fluid.

Titratable Trabeculotomy

To address the trabecular meshwork as a point of resistance within the conventional outflow pathway, the OMNI™ Surgical System lets you perform a titratable trabeculotomy customized to meet your surgical plan.

Intelligently engineered, implant free, disposable system

Intelligently engineered, implant free, disposable system

Play Video

One

MIGS device.

Two

implant-free procedures.

Three

points of resistance.

For

more patients.

Reimbursement Facts

Two distinct Category 1 CPT Codes associated with procedures that can be performed with the OMNI™ Surgical System
• 66174 – Transluminal canal dilation
• 65820 – Ab interno trabeculotomy

Request more info about the OMNI™ Surgical System

First Name*Email Address*Physical Address*State*

Last Name*Phone Number*City*Zip Code*

Are you a Cataract surgeon?*YesNo

How many procedures per month?

Are you a Glaucoma specialist?*YesNo

How many patients per month?

Are you MIGS trained?*YesNo

How many MIGS procedures per month?

Do you provide post-op care?*YesNo

Referral source

Interest in other Sight Sciences products?TearCare®

Important Safety Information

Indications for use

The OMNI™ Surgical System is a manually operated device for delivery of small amounts of viscoelastic fluid, for example Healon® or HealonGV® from Abbott Medical Optics (AMO), Amvisc® from Bausch & Lomb, or PROVISC® from Alcon, during ophthalmic surgery. It is also indicated to cut trabecular meshwork tissue during trabeculotomy procedures.

Disclaimer

The OMNI™ Surgical System is cleared (indicated) by FDA for the uses set forth above. While the OMNI system is not specifically cleared for transluminal canal dilation, there is support for its use (and the use of one of its parent devices, the VISCO360) in transluminal canal dilation in the literature and medical textbooks1,2,3,4, and ab interno trabeculotomy, for which it is FDA-cleared, is referred to as a MIGS procedure in the literature and medical textbooks and dictionaries.1,2,4,5,6

1. The OMNI™ System should not be used in cases where there is insufficient visualization of the anterior chamber. The following conditions may prohibit sufficient visualization required for safe and successful cannula and microcatheter placement: corneal edema, corneal haze, corneal opacity, or any other conditions that may inhibit surgeon view.

2. Monitor the patient postoperatively for proper maintenance of intraocular pressure. If intraocular pressure is not adequately maintained after surgery, appropriate management of intraocular pressure should be initiated, including medication or surgery.